Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

CV Death Rates in Autoimmune Disorders Waning, but Still Higher in Women

News Daily News

CV Death Rates in Autoimmune Disorders Waning, but Still Higher in Women

May 14, 2025

Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple

News Daily News

Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple

December 09, 2024

Atrial Fibrosis Mediated by Gum Disease May Be Missing AF Link

News Conference News AHA 2022

Atrial Fibrosis Mediated by Gum Disease May Be Missing AF Link

November 01, 2022

COVID-19: TCTMD’s Dispatch for January Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for January Week 2

January 10, 2022

COVID-19: TCTMD’s Dispatch for September Week 5

News Daily News

COVID-19: TCTMD’s Dispatch for September Week 5

September 27, 2021

COVID-19: TCTMD’s Daily Dispatch for September Week 1

News Daily News

COVID-19: TCTMD’s Daily Dispatch for September Week 1

August 30, 2021

PAD Continues to Elude Clinicians, Despite Gains: AHA

News Daily News

PAD Continues to Elude Clinicians, Despite Gains: AHA

August 05, 2021

Making the Case for Sex-Specific CVD Guidelines

News Daily News

Making the Case for Sex-Specific CVD Guidelines

July 08, 2021

COVID-19: TCTMD’s Daily Dispatch for June Week 3

News Daily News

COVID-19: TCTMD’s Daily Dispatch for June Week 3

June 11, 2021

Tocilizumab Improves Myocardial Salvage After STEMI: ASSAIL-MI

News Daily News

Tocilizumab Improves Myocardial Salvage After STEMI: ASSAIL-MI

Michael O'Riordan

April 12, 2021

COVID-19: TCTMD’s Daily Dispatch for February Week 2

News Daily News

COVID-19: TCTMD’s Daily Dispatch for February Week 2

February 08, 2021

Even Low-Dose Steroids Increase the Risk of CVD

News Daily News

Even Low-Dose Steroids Increase the Risk of CVD

Michael O'Riordan

December 03, 2020

Colchicine in the Crosshairs for Its High US Cost

News Daily News

Colchicine in the Crosshairs for Its High US Cost

December 01, 2020

FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat

News Daily News

FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat

February 22, 2019

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

News Features

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Michael O'Riordan

February 01, 2019

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Vote

News Daily News

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

January 11, 2019

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

News Daily News

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Michael O'Riordan

November 01, 2018

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

News Daily News

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Michael O'Riordan

April 25, 2018

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

News Daily News

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

Michael O'Riordan

April 24, 2018

My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up

News Conference News ACC 2018

My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up

March 27, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.